10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

CompletedOBSERVATIONAL
Enrollment

1,114

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Breast Cancer
Trial Locations (27)

Unknown

Research Site, Cheonan

Research Site, Chuncheon

Research Site, Goyang-si

Research Site, Seongnam-si

Research Site, Pohang

Research Site, Masan-si

Research Site, Anyang

Research Site, Busan

Research Site, Daegu

Research Site, Daejeon

Research Site, Gangneung

Research Site, GuangJu

Research Site, Gwangju

Research Site, Incheon

Research Site, Inchon

Research Site, Jeonju

Research Site, Junam

Research Site, Koyang

Research Site, Kyunggi

Research Site, Pusan

Research Site, Seoul

Research Site, Seoul(Kangbuk)

Research Site, Seoul(Kangdong)

Research Site, Seoul(Kangnam)

Research Site, Seoul(Yeouido)

Research Site, Suwon

Research Site, Ulsan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY